Calcific aortic stenosis.
Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P.
Nat Rev Dis Primers. 2016 Mar 3;2:16006. doi: 10.1038/nrdp.2016.6.
Left Ventricular Hypertrophy in Aortic Stenosis: Early Cell and Matrix Regression 2 Months Post-Aortic Valve Replacement.
Bennett J, Thornton GD, Nitsche C, Gama FF, Aziminia N, Gul U, Shetye A, Kellman P, Davies RH, Moon JC, Treibel TA; Barts Valve and Imaging Group.
Circ Cardiovasc Imaging. 2024 Dec;17(12):e017425. doi: 10.1161/CIRCIMAGING.124.017425. Epub 2024 Dec 4.
Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.
Pasipoularides A.
J Cardiovasc Transl Res. 2016 Aug;9(4):374-99. doi: 10.1007/s12265-016-9695-z. Epub 2016 May 16.
Absence of electrocardiographic left ventricular hypertrophy and poor outcome in patients undergoing transcatheter aortic valve replacement-A systematic review and meta-analysis.
Martha JW, Pranata R, Yonas E, Wibowo A, Akbar MR.
J Card Surg. 2021 Jul;36(7):2233-2239. doi: 10.1111/jocs.15515. Epub 2021 Mar 25.
Aortic valve replacement and mortality in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy.
Wasfy JH, Etiwy M, Zhao Y, Gustus SK, Berman AN, Fraccaro C, Karam N, Wasfy MM, Hsu J, Picard MH.
Eur J Cardiothorac Surg. 2025 Sep 2;67(9):ezaf211. doi: 10.1093/ejcts/ezaf211.
Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation: Insights from the OCEAN-TAVI Registry.
Koga M, Izumo M, Yoneyama K, Akashi YJ, Yashima F, Tada N, Yamawaki M, Shirai S, Naganuma T, Yamanaka F, Ueno H, Tabata M, Mizutani K, Takagi K, Watanabe Y, Yamamoto M, Hayashida K; OCEAN-TAVI Investigators.
Am J Cardiol. 2023 Oct 1;204:130-139. doi: 10.1016/j.amjcard.2023.07.101. Epub 2023 Aug 2.
Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease.
Kim M, Choi JH, Kim HK, Kim HL, Shin SH, Jang JY, Park JH, Kim KH, Hong GR, Park SM, Lee SA, Kang DH.
Am Heart J. 2024 Feb;268:45-52. doi: 10.1016/j.ahj.2023.11.012. Epub 2023 Nov 23.
Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function.
Dahiya G, Kyvernitakis A, Joshi AA, Lasorda DM, Bailey SH, Raina A, Biederman RWW, Kanwar MK.
Int J Cardiovasc Imaging. 2021 Feb;37(2):485-492. doi: 10.1007/s10554-020-02015-z. Epub 2020 Sep 9.
Preventing Ventricular Fibrillation in Patients With Left Ventricular Hypertrophy Undergoing Aortic Valve Replacement: Time to Consider Prophylactic Amiodarone Infusion.
Dalia AA, Essandoh MK.
J Cardiothorac Vasc Anesth. 2019 May;33(5):1214-1215. doi: 10.1053/j.jvca.2018.11.022. Epub 2018 Nov 17.
Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement.
Pedersen ALD, Povlsen JA, Rasmussen VG, Frederiksen CA, Christiansen EH, Terkelsen CJ, Vase H, Poulsen SH.
Int J Cardiovasc Imaging. 2023 Jan;39(1):13-22. doi: 10.1007/s10554-022-02688-8. Epub 2022 Jul 19.
